oxazoles has been researched along with Cardiomyopathies in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atkinson, JB; Carrier, EJ; Galindo, CL; Kim, K; Knollmann, BC; Macias-Perez, I; Markham, LW; Pavliv, L; Shin, JJ; Soslow, JH; West, JD | 1 |
| Just, S; Köhler, D; Pott, A; Pylatiuk, C; Rottbauer, W; Shahid, M; Weinmann, K | 1 |
| Bryant, PA; Curtis, N; Dargaville, PA; Starr, M; Tingay, D | 1 |
| Ceska, R; Stulc, T | 1 |
| Bousquet, PP; Monassier, LJ; Signolet, IL | 1 |
5 other study(ies) available for oxazoles and Cardiomyopathies
| Article | Year |
|---|---|
Antagonism of the Thromboxane-Prostanoid Receptor as a Potential Therapy for Cardiomyopathy of Muscular Dystrophy.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Cardiomyopathies; Disease Models, Animal; Female; Male; Mice; Mice, Inbred mdx; Mice, Knockout; Muscular Dystrophy, Duchenne; Oxazoles; Prostaglandin Antagonists; Random Allocation; Receptors, Thromboxane | 2019 |
Therapeutic Chemical Screen Identifies Phosphatase Inhibitors to Reconstitute PKB Phosphorylation and Cardiac Contractility in ILK-Deficient Zebrafish.
Topics: Animals; Apoptosis; Cardiomyopathies; Disease Models, Animal; Enzyme Inhibitors; Humans; Marine Toxins; Myocardial Contraction; Okadaic Acid; Oxazoles; Phosphoric Monoester Hydrolases; Phosphorylation; Protein Serine-Threonine Kinases; Signal Transduction; Zebrafish; Zebrafish Proteins | 2018 |
Neonatal coxsackie B virus infection-a treatable disease?
Topics: Antiviral Agents; Cardiomyopathies; Coxsackievirus Infections; Disseminated Intravascular Coagulation; Enterovirus B, Human; Hepatitis; Humans; Infant; Infant, Newborn; Infant, Premature; Infectious Disease Transmission, Vertical; Meningoencephalitis; Oxadiazoles; Oxazoles; Perinatal Care; Polymerase Chain Reaction; Thrombocytopenia | 2004 |
Is it safe to combine PPAR agonists? A lesson from muraglitazar.
Topics: Cardiomyopathies; Drug Interactions; Glycine; Humans; Models, Biological; Oxazoles; PPAR alpha; PPAR gamma | 2006 |
Improvement of cardiac diastolic function by long-term centrally mediated sympathetic inhibition in one-kidney, one-clip hypertensive rabbits.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Cardiomyopathies; Diastole; Disease Models, Animal; Heart Rate; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Ligation; Male; Metoprolol; Myocardial Contraction; Nephrectomy; Oxazoles; Rabbits; Renal Artery; Rilmenidine; Sympathetic Nervous System; Systole; Time Factors; Ultrasonography; Ventricular Function; Ventricular Remodeling | 2008 |